[go: up one dir, main page]

ES8801673A1 - Un procedimiento para la preparacion de derivados peptidicos de histidinilprolinamida. - Google Patents

Un procedimiento para la preparacion de derivados peptidicos de histidinilprolinamida.

Info

Publication number
ES8801673A1
ES8801673A1 ES557149A ES557149A ES8801673A1 ES 8801673 A1 ES8801673 A1 ES 8801673A1 ES 557149 A ES557149 A ES 557149A ES 557149 A ES557149 A ES 557149A ES 8801673 A1 ES8801673 A1 ES 8801673A1
Authority
ES
Spain
Prior art keywords
formula
processes
production
compositions containing
imino group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES557149A
Other languages
English (en)
Other versions
ES557149A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Publication of ES557149A0 publication Critical patent/ES557149A0/es
Publication of ES8801673A1 publication Critical patent/ES8801673A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR DERIVADOS PEPTIDICOS DE HISTIDINILPROLINAMIDA. CONSISTE EN CONDENSAR UN COMPUESTO DE FORMULA (II) CON UN PROLINAMIDA DE FORMULA (III),EN PRESENCIA DE UN ACEPTOR DE ACIDO (HIDROXIDO SODICO), EN UN DISOLVENTE (TETRAHIDROFURANO) Y ENTRE C30 Y B50JC, PARA OBTENER UN COMPUESTO DE FORMULA (I) Y SU SAL FARMACEUTICAMENTE ACEPTABLE. SIENDO: R, H O ALQUILO INFERIOR; X1, UN GRUPO IMINO O UN GRUPO ALQUILIMINO INFERIOR; X2, UN GRUPO IMINO; Y X3, UN GRUPO IMINO O UNA SAL DEL MISMO. SE UTILIZA PARA EL TRATAMIENTO DE LOS TRASTORNOS DEL SISTEMA NERVIOSO CENTRAL.
ES557149A 1985-02-20 1986-10-27 Un procedimiento para la preparacion de derivados peptidicos de histidinilprolinamida. Expired ES8801673A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB08504357A GB2171101A (en) 1985-02-20 1985-02-20 Peptide and processes for preparation of the same

Publications (2)

Publication Number Publication Date
ES557149A0 ES557149A0 (es) 1988-02-16
ES8801673A1 true ES8801673A1 (es) 1988-02-16

Family

ID=10574792

Family Applications (2)

Application Number Title Priority Date Filing Date
ES552193A Expired ES8705464A1 (es) 1985-02-20 1986-02-19 Un procedimiento para la preparacion de nuevos peptidos.
ES557149A Expired ES8801673A1 (es) 1985-02-20 1986-10-27 Un procedimiento para la preparacion de derivados peptidicos de histidinilprolinamida.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES552193A Expired ES8705464A1 (es) 1985-02-20 1986-02-19 Un procedimiento para la preparacion de nuevos peptidos.

Country Status (9)

Country Link
US (1) US4711878A (es)
EP (1) EP0194443B1 (es)
JP (1) JPS61191695A (es)
AT (1) ATE45958T1 (es)
CA (1) CA1265898A (es)
DE (1) DE3665309D1 (es)
ES (2) ES8705464A1 (es)
GB (1) GB2171101A (es)
HK (1) HK1591A (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL75641A (en) * 1984-07-10 1990-11-05 Tanabe Seiyaku Co 1-methyl-4,5-dihydro-orotyl-histidyl-prolinamide,its preparation and pharmaceutical compositions comprising it
US5686420A (en) * 1987-06-05 1997-11-11 Georgetown University Thyrotropin-releasing hormone analogs and method of use
JPS63316724A (ja) * 1987-06-19 1988-12-26 Nippon Shinyaku Co Ltd 抗けいれん剤
US7462595B2 (en) * 2004-09-17 2008-12-09 Prange Jr Arthur Jergen Methods for treating cancer-related fatigue
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL183764C (nl) * 1974-10-16 1989-01-16 Gruenenthal Gmbh Werkwijze voor de bereiding van een geneesmiddel met psychotrope of neurotrope werking en werkwijze voor de bereiding van een histidylprolineamide-derivaat.
JPS51118841A (en) * 1975-04-03 1976-10-19 Takeda Chem Ind Ltd A drug for improving and treating clouding of consciousness
JPS5944308B2 (ja) * 1976-03-23 1984-10-29 武田薬品工業株式会社 ペプタイド

Also Published As

Publication number Publication date
JPS61191695A (ja) 1986-08-26
US4711878A (en) 1987-12-08
HK1591A (en) 1991-01-11
ES557149A0 (es) 1988-02-16
ATE45958T1 (de) 1989-09-15
ES8705464A1 (es) 1987-05-01
GB8504357D0 (en) 1985-03-20
CA1265898A (en) 1990-02-13
EP0194443B1 (en) 1989-08-30
EP0194443A3 (en) 1987-09-23
ES552193A0 (es) 1987-05-01
EP0194443A2 (en) 1986-09-17
JPH0564960B2 (es) 1993-09-16
DE3665309D1 (en) 1989-10-05
GB2171101A (en) 1986-08-20

Similar Documents

Publication Publication Date Title
ES8604111A1 (es) Procedimiento para preparar el compuesto 3-amino-3-deoxi-es-tanina
ES8800682A1 (es) Un procedimiento para la preparacion de nuevas (4-piperidinilmetil y heteropurinas)
ES8900017A1 (es) Procedimiento para la preparacion de dipeptidos de n,n-dialquil-guanidino.
ES2061660T3 (es) Eteres azabiciclicos.
ES8707733A1 (es) Un procedimiento para la preparacion de triazolobenzodiazepinas
ES8707220A1 (es) Un metodo para sintetizar compuestos de ascorbato-2-polifosfato
ES8203376A1 (es) Procedimiento para obtener acidos 6-cloro- o 6-bromo-1,2-di-hidro-3h-pirrolo(1,2-a)pirrol-1-carboxilicos y sus derivados
ES8801903A1 (es) Procedimiento para preparar derivados de cinolina
ES8801174A1 (es) Un procedimiento para la preparacion de derivados de tetrahidronaftaleno.
ES8504202A1 (es) Procedimiento para la obtencion de nuevos derivados de sinergistinas
ES8801673A1 (es) Un procedimiento para la preparacion de derivados peptidicos de histidinilprolinamida.
GB1301973A (es)
ES2040856T3 (es) Un procedimiento para preparar un compuesto de tiofeno.
GB1297386A (es)
ES8502121A1 (es) Derivados del acido 7 b-((z)-2-(2-aminotiazol-4-il)-2-oximinoacetamido)-3-cefem-4-carboxilico
GB1228736A (es)
GB1178658A (en) Indene Derivatives and Production thereof
ES2128554T3 (es) Nuevos derivados del acido glutamico, procedimiento para su preparacion y su utilizacion como medicamentos para el aumento de la memoria y aprendizaje.
GB1417542A (en) Theophylline 7acetate salts
ES8501763A1 (es) "procedimiento para la fabricacion de derivados de la tetrahidro-5.6.7.7. 4h-tieno (3, 2-c) piridinona-2
ES8304122A1 (es) "procedimiento para la preparacion de derivados triptaminicos sustituidos de tieniloxipropanolaminas, racemicos y opticamente activos".
PE41896A1 (es) Antagonista del receptor de aminoacido excitativo
ES8707738A1 (es) Un procedimiento para la preparacion de 1-metil-4,5-dihidroorotil-histidil-prolinamida
GB1252329A (es)
ES8703480A1 (es) Un procedimiento para producir un derivado de ester de cefe-losporina